Online Makale
Online Hizmetlere Toplu BakışHaydarpasa Numune Egitim ve Arastirma Hastanesi Tip Dergisi
Haydarpasa Numune Med J. 2023; 63(4): 531-536 | DOI: 10.14744/hnhj.2022.43765 | |||
The Prognostic Significance of Glucose Transporter-1 Protein in Malignant Pleural MesotheliomaTalha Doğruyol1, Levent Alpay2, Deniz Gürer3, Ayşe Ersev4, Cansel Atinkaya Baytemir2, Serdar Evman2, Volkan Baysungur2, İrfan Yalçınkaya21Department of Thoracic Surgery, Manisa State Hospital, Manisa, Türkiye2Department of Thoracic Surgery, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkiye 3Department of Thoracic Surgery, Istanbul Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Türkiye 4Department of Pathology, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Türkiye INTRODUCTION: Malignant pleural mesothelioma (MPM) is a rare condition with a poor survival rate. This study was designed to determine the prognostic importance of glucose transporter-1 (GLUT-1) expression in operated patients with pleural mesothelioma. Talha Doğruyol, Levent Alpay, Deniz Gürer, Ayşe Ersev, Cansel Atinkaya Baytemir, Serdar Evman, Volkan Baysungur, İrfan Yalçınkaya. The Prognostic Significance of Glucose Transporter-1 Protein in Malignant Pleural Mesothelioma. Haydarpasa Numune Med J. 2023; 63(4): 531-536 Sorumlu Yazar: Talha Doğruyol, Türkiye |
|